The size of the North American enteral feeding devices market was worth USD 0.8 billion in 2023. This value is estimated to grow at a CAGR of 4.81% and reach USD 1.02 billion by 2028.
The growth of the enteral feeding devices market in North America is primarily driven by the rising geriatric population suffering from various disorders. The impact of advanced dementia is particularly notable among the elderly population who face difficulties in consuming food. In such scenarios, enteral feeding devices have proven to be a valuable aid. According to estimates, around 7 million Americans aged above 65 years are affected by dementia, and this number is predicted to rise in the coming years. Enteral feeding devices are typically placed through the nose, down the throat, or directly into the stomach through a small hole to ensure the body receives the necessary nutrition. Consequently, the demand for enteral feeding devices is expected to remain robust in the coming years.
The growing incidence of cancer in North American countries is another notable factor propelling the regional market growth. Patients with head and neck cancer may have trouble consuming food normally, which can result in malnutrition. In such cases, enteral feeding devices often provide adequate nutrition to support the body's fight against cancer. As the number of cancer cases continues to increase in North American countries, the demand for enteral feeding devices is expected to rise steadily in the coming years. This trend underscores the significance of these devices in supporting patients undergoing cancer treatment. It highlights the potential for continued growth and expansion of the enteral feeding devices market in the region.
The rising number of preterm births contributes to the growth of the enteral feeding devices market in North America. Nutritional management is crucial for neonates in intensive care units, and enteral feeding devices are often used to provide necessary nutrients for their growth and development. These devices aid in the development of gastrointestinal mucosa, intestinal motility, enzyme synthesis, and hormonal release while also reducing several risks for the baby. The rising prevalence of chronic diseases in North America, along with the presence of advanced healthcare infrastructure and rising healthcare spending are additional factors expected to drive the growth of the enteral feeding devices market. Furthermore, increasing awareness among patients about the benefits of enteral feeding devices is anticipated to fuel market growth in the region further. These factors collectively highlight the significant potential for growth and expansion of the enteral feeding devices market in North America in the foreseeable future.
One such issue is the increasing incidence of complications associated with enteral tubes, including misconnection in the body. These complications are negatively impacting the market growth. Moreover, a lack of trained professionals and unfavorable reimbursement policies are further restraining the market growth in North America. Additionally, the increasing incidence of medication errors associated with enteral feeding is also impeding the growth of the enteral feeding devices market. Furthermore, the high costs associated with the installation and maintenance of enteral feeding devices are also showcasing a negative impact on the growth rate of the North American market.
This research report on the North American enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
The enteral feeding tubes segment led the North American market in 2021.
The pediatrics segment is the most lucrative in the North American market by stage.
The oncology segment had the largest share of the North American market in 2021.
By End User:
The hospital segment accounted for the major share of the North American market in 2021.
The North American region emerged as the largest segment in the global enteral feeding devices market in 2021 and is expected to maintain its dominance during the forecast period owing to the growing healthcare spending and the presence of advanced healthcare infrastructure in hospitals across the region. Moreover, the growing awareness among the people of North America about the benefits of enteral feeding devices has led to an increase in their adoption, particularly when dealing with illness or recovery. This trend is expected to fuel further the growth of the enteral feeding devices market in the region. Additionally, the presence of key market players in North America is a significant factor contributing to regional market growth. These companies are strategically positioned to leverage the opportunities offered by the region's favorable market conditions, thereby supporting the overall growth of the enteral feeding devices market in North America.
The U.S. held the largest share of the North American market in 2022 and is predicted to continue the trend throughout the forecast period owing to the growing number of product approvals in the U.S. In 2022, Rockfield Medical Devices Limited significantly contributed to this trend by developing a portable system called the Mobility+ Enteral Feeding System, which received approval from the United States Food and Drug Administration (FDA). This device is designed to enhance the quality of life for individuals reliant on tube feeding, providing a lightweight and non-electronic solution suitable for patients aged 2 years and above. Within the US market, enteral feeding devices are widely used in intensive care settings, particularly for ventilated patients. Several tubes are employed for this purpose, including orogastric tubes (OGTs), nasogastric tubes, and Dobhoff tubes. These developments in the US market are significant, both in terms of their potential impact on the healthcare industry and as examples of innovative solutions being brought to market. As such, they are worthy of close attention from business leaders seeking to stay abreast of emerging trends and opportunities within this sector.
The Canadian market for enteral feeding devices is poised for robust growth in the coming years owing to the growing number of survey activities focused on home enteral nutrition, a critical therapy for patients who cannot consume nutrition orally. Moreover, the Canadian market benefits from supportive reimbursement policies, encouraging demand for enteral nutrition products among eligible patients. As a result, this market presents a compelling opportunity for businesses seeking to invest in this field. Additionally, the increasing number of clinical trials aimed at developing new and innovative enteral feeding devices further contributes to the market's growth potential. These developments underscore the significance of the Canadian market as a vital player in the North American healthcare landscape, deserving of close attention from industry leaders looking to capitalize on emerging trends and opportunities.
Key Market Players:
Companies playing a dominant role in the North American Enteral Feeding Devices Market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE., Covidien PLC, Cook Medical, and Nestle S.A.
The North America Enteral Feeding Devices Market is expected to be worth 970 million by 2027.
2021 has taken as the base year and 2022 to 2027 is the forecast period for this report.
The growing aging population and increasing preterm births are propelling the market growth in North America.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com